Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
Min ZhaoRebecca SlotkinAmar H ShethLauren PischelTassos C KyriakidesBrinda EmuCynthia McNamaraQiaosu ShiJaden DelgobboJin XuElizabeth MarhofferAleagia Mercer-FalkoffJürgen HolleckDavid ArditoRichard E SuttonShaili GuptaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Multiple clinical factors impact the strength and duration of neutralization response post-primary series vaccination, but not the post-booster dose strength. Malignancy was associated with lower booster-dose response regardless of prior COVID infection, suggesting a need for clinically guided vaccine regimens.
Keyphrases